SenesTech (NASDAQ:SNES) Research Coverage Started at StockNews.com

Posted by Defense World Staff on Jun 2nd, 2024

Analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $3.50 price target on shares of SenesTech in a research note on Tuesday, May 14th.

Check Out Our Latest Analysis on SenesTech

SenesTech Stock Performance

SNES stock opened at $0.75 on Friday. The business’s fifty day moving average is $0.74 and its 200-day moving average is $0.95. The company has a debt-to-equity ratio of 0.03, a current ratio of 6.91 and a quick ratio of 5.69. SenesTech has a twelve month low of $0.52 and a twelve month high of $16.56.

SenesTech (NASDAQ:SNES – Get Free Report) last posted its quarterly earnings results on Thursday, May 9th. The company reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). The company had revenue of $0.42 million during the quarter, compared to analyst estimates of $0.43 million. SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. During the same period last year, the company earned ($15.85) EPS. Research analysts predict that SenesTech will post -1.1 earnings per share for the current fiscal year.

Hedge Funds Weigh In On SenesTech

An institutional investor recently bought a new position in SenesTech stock. Armistice Capital LLC acquired a new stake in SenesTech, Inc. (NASDAQ:SNES – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned approximately 1.94% of SenesTech at the end of the most recent reporting period. 5.19% of the stock is owned by institutional investors and hedge funds.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Receive News & Ratings for SenesTech Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for SenesTech and related companies with MarketBeat.com’s FREE daily email newsletter.